IL141675A0 - Immunogenic liposome compositions - Google Patents

Immunogenic liposome compositions

Info

Publication number
IL141675A0
IL141675A0 IL14167599A IL14167599A IL141675A0 IL 141675 A0 IL141675 A0 IL 141675A0 IL 14167599 A IL14167599 A IL 14167599A IL 14167599 A IL14167599 A IL 14167599A IL 141675 A0 IL141675 A0 IL 141675A0
Authority
IL
Israel
Prior art keywords
liposome compositions
immunogenic liposome
immunogenic
compositions
liposome
Prior art date
Application number
IL14167599A
Other languages
English (en)
Original Assignee
Molecular Express Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Express Inc filed Critical Molecular Express Inc
Publication of IL141675A0 publication Critical patent/IL141675A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55555Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/03Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/40Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24211Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IL14167599A 1998-09-22 1999-09-22 Immunogenic liposome compositions IL141675A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10135198P 1998-09-22 1998-09-22
US40072399A 1999-09-21 1999-09-21
PCT/US1999/020880 WO2000016746A2 (en) 1998-09-22 1999-09-22 Immunogenic liposome compositions

Publications (1)

Publication Number Publication Date
IL141675A0 true IL141675A0 (en) 2002-03-10

Family

ID=26798150

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14167599A IL141675A0 (en) 1998-09-22 1999-09-22 Immunogenic liposome compositions
IL141675A IL141675A (en) 1998-09-22 2001-02-27 Immunogenic liposome vaccines

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL141675A IL141675A (en) 1998-09-22 2001-02-27 Immunogenic liposome vaccines

Country Status (31)

Country Link
EP (1) EP1115382B1 (sk)
JP (1) JP2002526436A (sk)
KR (1) KR100592825B1 (sk)
CN (1) CN1555254A (sk)
AP (1) AP2010A (sk)
AT (1) ATE468108T1 (sk)
AU (1) AU766772B2 (sk)
BG (1) BG65675B1 (sk)
BR (1) BR9914004A (sk)
CA (1) CA2344173C (sk)
CY (1) CY1110718T1 (sk)
CZ (1) CZ20011013A3 (sk)
DE (1) DE69942393D1 (sk)
DK (1) DK1115382T3 (sk)
EA (1) EA004797B1 (sk)
EE (1) EE200100168A (sk)
ES (1) ES2345695T3 (sk)
GE (1) GEP20053444B (sk)
HK (1) HK1039064A1 (sk)
HU (1) HUP0105391A3 (sk)
ID (1) ID29082A (sk)
IL (2) IL141675A0 (sk)
MX (1) MXPA01002973A (sk)
NO (1) NO330685B1 (sk)
NZ (2) NZ528055A (sk)
OA (1) OA11657A (sk)
PL (1) PL206260B1 (sk)
SK (1) SK287670B6 (sk)
UA (1) UA75327C2 (sk)
WO (1) WO2000016746A2 (sk)
ZA (1) ZA200101829B (sk)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200726479A (en) 2005-04-12 2007-07-16 Univ Duke Method of inducing neutralizing antibodies to human immunodeficiency virus
KR102185682B1 (ko) 2009-06-04 2020-12-11 고쿠리츠칸센쇼켄쿠죠 마이코플라즈마 감염증용 백신
CA2834349A1 (en) 2011-04-26 2012-11-01 Molecular Express, Inc. Liposomal formulations
WO2015048635A1 (en) 2013-09-27 2015-04-02 Duke University Mper-liposome conjugates and uses thereof
CA3057715A1 (en) * 2017-04-04 2018-10-11 Avidea Technologies, Inc. Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response
KR20240033309A (ko) * 2022-09-05 2024-03-12 주식회사 차백신연구소 에멀전 제형의 면역증강제 조성물 및 이의 제조 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8405493D0 (sv) * 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US5374548A (en) * 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
SE462375B (sv) * 1985-10-15 1990-06-18 Morgaardshammar Ab Centro Traadblock
US4861597A (en) * 1986-05-20 1989-08-29 Wako Pure Chemical Industries, Ltd. Novel functionallized liposomes and a process for production thereof
FR2754543B1 (fr) * 1996-10-11 1998-12-31 Pasteur Institut Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires

Also Published As

Publication number Publication date
OA11657A (en) 2004-12-08
KR100592825B1 (ko) 2006-06-23
NO330685B1 (no) 2011-06-06
CA2344173A1 (en) 2000-03-30
AU6035199A (en) 2000-04-10
ZA200101829B (en) 2002-06-05
EP1115382A2 (en) 2001-07-18
PL206260B1 (pl) 2010-07-30
IL141675A (en) 2007-06-17
EP1115382B1 (en) 2010-05-19
AU766772B2 (en) 2003-10-23
WO2000016746A3 (en) 2000-11-23
NZ528055A (en) 2005-01-28
KR20010075261A (ko) 2001-08-09
BR9914004A (pt) 2001-07-24
CN1555254A (zh) 2004-12-15
HUP0105391A3 (en) 2006-02-28
WO2000016746A9 (en) 2000-09-21
DE69942393D1 (de) 2010-07-01
HUP0105391A2 (hu) 2002-05-29
NO20011406L (no) 2001-04-24
DK1115382T3 (da) 2010-09-06
MXPA01002973A (es) 2003-03-27
HK1039064A1 (en) 2002-04-12
BG65675B1 (bg) 2009-06-30
NO20011406D0 (no) 2001-03-20
AP2010A (en) 2009-06-29
NZ510442A (en) 2003-10-31
SK287670B6 (sk) 2011-05-06
EE200100168A (et) 2002-06-17
WO2000016746A2 (en) 2000-03-30
CY1110718T1 (el) 2015-06-10
EA200100269A1 (ru) 2001-12-24
AP2001002096A0 (en) 2001-03-31
ID29082A (id) 2001-07-26
UA75327C2 (en) 2006-04-17
JP2002526436A (ja) 2002-08-20
ATE468108T1 (de) 2010-06-15
SK3222001A3 (en) 2001-09-11
EA004797B1 (ru) 2004-08-26
WO2000016746A8 (en) 2000-08-10
GEP20053444B (en) 2005-02-25
CA2344173C (en) 2010-02-23
PL348604A1 (en) 2002-06-03
BG105372A (en) 2001-10-31
ES2345695T3 (es) 2010-09-29
CZ20011013A3 (cs) 2002-03-13

Similar Documents

Publication Publication Date Title
HUP0101047A3 (en) Combined vaccine compositions
IL137999A0 (en) Vaccine compositions
HUP0101619A3 (en) Adjuvant compositions
AP2000001874A0 (en) Cellecoxib compositions
GB9811377D0 (en) Compositions
EP1154755A4 (en) Liposomes FORMULATIONS
GB9811457D0 (en) Rotor
GB9801870D0 (en) Vaccine composition
PL348604A1 (en) Immunogenic liposome compositions
GB9824075D0 (en) Rotor
GB2339693B (en) Anti-mollusc compositions
GB9805782D0 (en) Compositions
GB9822158D0 (en) Compositions
GB9812818D0 (en) Dentfrice compositions
GB9827291D0 (en) Compositions
GB9806810D0 (en) Compositions
GB2336535B (en) Compositions
GB9809347D0 (en) Compositions
GB9816050D0 (en) Compositions
GB9818278D0 (en) Compositions
GB9806455D0 (en) Vaccine composition
GB9802879D0 (en) Vaccine composition
GB9803008D0 (en) Compositions
GB9808294D0 (en) Compositions
GB9808595D0 (en) Compositions

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees
NE Application for restoration - patent lapsed through non-payment of renewal fees (section 60, patents law, 5727-1967)